Antineuronal antibodies: Anti-recoverin in neurological syndromes without retinopathy. SARS-CoV2 infection as a trigger

Neurologia (Engl Ed). 2022 Jun;37(5):409-410. doi: 10.1016/j.nrleng.2021.07.003. Epub 2022 Mar 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies
  • COVID-19*
  • Humans
  • RNA, Viral
  • Recoverin
  • Retinal Diseases*
  • SARS-CoV-2
  • Syndrome

Substances

  • Antibodies
  • RNA, Viral
  • Recoverin